ARA-290 16 mg – Peptide Hubs
ARA-290 is a synthetic peptide derivative of erythropoietin (EPO) engineered for tissue protection without affecting red blood cell production. The 16 mg lyophilized vial from Peptide Hubs offers researchers a powerful tool for studying neuropathic pain, inflammation modulation, and autoimmune disorders without the hematopoietic effects of full-length EPO.
What Is ARA-290?
ARA-290 is an 11-amino-acid peptide developed to selectively activate the innate repair receptor (IRR), which plays a role in tissue protection and anti-inflammatory responses. It has shown promise in preclinical studies for reducing chronic pain, improving insulin sensitivity, and modulating immune response in conditions such as sarcoidosis, small fiber neuropathy, and diabetes-related nerve damage.
Mechanism of Action
Unlike erythropoietin, which activates both EPOR and IRR, ARA-290 binds exclusively to the IRR. This avoids the red blood cell–producing side effects of EPO while retaining its beneficial effects on damaged tissues. It is currently being studied for its ability to reduce oxidative stress, inflammation, and nerve pain in both animal and human clinical trials. For a detailed molecular breakdown, refer to this NIH publication on ARA-290.
Applications in Research
ARA-290 is gaining popularity in neuroscience, diabetes, and inflammatory condition research due to its neuroprotective and regenerative potential. Bodybuilders and biohackers also express interest in ARA-290 for its off-label anti-inflammatory effects post-cycle, especially when combined with agents like BPC-157 or GHK-CU.
Technical Details
Peptide Type
Erythropoietin-Derived Peptide
Peptide Sequence
QEQLERALNSS
Peptide Length
11 Amino Acids
Molecular Formula
Cβ
βHββNββOββ
Molecular Weight
1257.3 g/mol
Research Target
Innate Repair Receptor (IRR)
Receptor Complex
EPOR / CD131
Development Status
Investigational
Dosage & Usage Guidelines
- Dose: 4–8 mg per day
- Administration: Subcutaneously, usually in morning or post-activity
- Cycle: 5–20 days depending on research protocol
Researchers sometimes administer ARA-290 alongside Semax for cognitive or neurogenic support in central nervous system–related studies.
Stacking Options
To enhance regenerative pathways and reduce systemic inflammation, ARA-290 is commonly stacked with:
- BPC-157 – tissue and gut repair
- Melanotan II – improved skin resilience and photo-protection
- AOD 9604 – for metabolic regulation
Side Effects and Safety
ARA-290 has a low risk profile. Studies show no elevation in hematocrit or hemoglobin, which is a common concern with full-length EPO. Mild injection site irritation and rare fatigue are reported in some cases. It does not affect hormonal pathways, liver enzymes, or cause water retention or androgenic side effects.
Legal Disclaimer
ARA-290 is sold strictly for laboratory and research purposes. It is not approved by the FDA for human consumption. Usage must comply with research-only guidelines. For information on WADA status and potential clinical trial data, visit the ClinicalTrials.gov database.
Shipping & Product Authenticity
USA Domestic
4–5 business days
International
13–15 business days
Order Processing
24–48 business hours
Tracking
Tracking number provided
Direct Supply & Discreet Delivery
This product is supplied through the official Peptide Hubs distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
What to Expect
- β Orders are processed after payment confirmation
- β USA Domestic shipping is typically faster when local stock is selected
- β International orders include tracking, though update frequency may vary by destination
- β Multiple warehouses may result in separate shipments when applicable
Authenticity support: official Peptide Hubs presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
Verified Supply
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.
After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices during research use.
Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.
Frequently Asked Questions
What is ARA-290 used for?
ARA-290 is a research peptide used to study neuropathic pain, inflammation, and tissue regeneration without impacting red blood cell production.
How does ARA-290 differ from EPO?
ARA-290 selectively activates the innate repair receptor (IRR) without affecting erythropoiesis, avoiding the blood-thickening effects associated with EPO.
Is ARA-290 safe for human use?
No, ARA-290 is not FDA-approved and is intended only for research purposes. It is not legal for human consumption outside of clinical studies.
Can ARA-290 be stacked with other peptides?
Yes, researchers often stack ARA-290 with BPC-157, GHK-CU, or Semax in studies focused on healing, inflammation, or neurological recovery.
No reviews found
Please log in to write ARA-290 16 mg review.